ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Stivarga 40 mg, Filmtabletten - 3 x 28 Tablette(n)
62808002 PPBayer (Schweiz) AG
Stivarga 40 mg, Filmtabletten27.02.2013
  27.02.2013
Regorafenib (L01XE21) 
WHO-DDD26.02.2023
07.16.10.3 x 28 Tablette(n)
07.16.10. 
A  
Yes 
IPCI
3202.02Yes
    
10 %3528.05
  
7680628080023Synthetika
5549771 
Composition
regorafenibum 40 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 14.01 mg, magnesii stearas, povidonum, silica colloidalis anhydrica, Überzug: lecithinum ex soja, macrogolum 3350, poly(alcohol vinylicus), talcum, E 172 (rubrum), E 172 (flavum), E 171, pro compresso obducto.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Regorafenibum40 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Rubrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Lecithinum ex Soja Überzug
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus)  
Povidone  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
Source
Data was imported : 05.08.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2020 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home